U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H26BrNOS
Molecular Weight 408.396
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIOBROMADOL

SMILES

CN(C)[C@]1(CC[C@@](O)(CCC2=CC=CS2)CC1)C3=CC=C(Br)C=C3

InChI

InChIKey=XRDNIYBVNZLPJE-MXVIHJGJSA-N
InChI=1S/C20H26BrNOS/c1-22(2)20(16-5-7-17(21)8-6-16)13-11-19(23,12-14-20)10-9-18-4-3-15-24-18/h3-8,15,23H,9-14H2,1-2H3/t19-,20-

HIDE SMILES / InChI

Molecular Formula C20H26BrNOS
Molecular Weight 408.396
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:59:14 GMT 2023
Edited
by admin
on Sat Dec 16 17:59:14 GMT 2023
Record UNII
D343S4VX5G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
THIOBROMADOL
Common Name English
CYCLOHEXANOL, 4-(4-BROMOPHENYL)-4-(DIMETHYLAMINO)-1-(2-(2-THIENYL)ETHYL)-, TRANS-
Systematic Name English
C-8813
Code English
TRANS-4-(4-BROMOPHENYL)-4-(DIMETHYLAMINO)-1-(2-(2-THIENYL)ETHYL)CYCLOHEXANOL
Systematic Name English
Code System Code Type Description
PUBCHEM
11058633
Created by admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
PRIMARY
FDA UNII
D343S4VX5G
Created by admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
PRIMARY
WIKIPEDIA
C-8813
Created by admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
PRIMARY
CAS
616898-54-5
Created by admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
PRIMARY
EPA CompTox
DTXSID90101841
Created by admin on Sat Dec 16 17:59:15 GMT 2023 , Edited by admin on Sat Dec 16 17:59:15 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
In the MVD, C8813 could inhibit the electrically induced contraction, but weaker than in the GPI. Moreover, this inhibitory effect could antagonized by the δ-opioid receptor antagonist ICI174864. These results indicated C8813 also acted on δ-opioid receptor but less potent than on μ-opioid receptor.
OFF TARGET->NON-INHIBITOR
TARGET -> AGONIST
In mouse hot plate test, the antinociceptive ED50 of C8813 was 11.5 μg/kg, being 591 times and 3.4 times more potent than morphine and fentanyl respectively.
Ki